S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
He Is Giving Away Bitcoin (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
You won't believe what Citigroup just did to it's depositors (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
He Is Giving Away Bitcoin (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
You won't believe what Citigroup just did to it's depositors (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
He Is Giving Away Bitcoin (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
You won't believe what Citigroup just did to it's depositors (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
He Is Giving Away Bitcoin (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
You won't believe what Citigroup just did to it's depositors (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Free Trial
CNSX:LXX

Lexaria Bioscience (LXX) Stock Price, News & Analysis

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)
Free LXX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
48,200 shs
Average Volume
250,001 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
LXX stock logo

About Lexaria Bioscience Stock (CNSX:LXX)

Lexaria Bioscience Corp. focuses on the development of its proprietary nutrient infusion technologies for the production of superfoods. It operates in two segments, Intellectual Property Licensing and Consumer Products. The company develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, NSAIDs, nicotine, and other molecules. It is also involved in the development, production, and distribution of enhanced functional food and supplement products under the ViPova and Lexaria Energy brands. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was founded in 2004 and is based in Kelowna, Canada.

LXX Stock News Headlines

April 9, 2024 | msn.com
LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024
February 22, 2024 | benzinga.com
Lexaria Bioscience Stock (NASDAQ:LEXXW) Dividends: History, Yield and Dates
April 16, 2024 | InvestorPlace (Ad)
Forget Nvidia, buy this A.I. Stock Now
Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.
January 30, 2024 | msn.com
Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD
December 1, 2023 | markets.businessinsider.com
Buy Rating on Lexaria Bioscience: Promising DehydraTECH Study and Market Potential
November 27, 2023 | msn.com
Lexaria stock rallies 20% on positive GLP-1 drug delivery study
July 22, 2023 | msn.com
Maxim Group Initiates Coverage of Lexaria Bioscience (LEXX) with Buy Recommendation
June 16, 2023 | benzinga.com
Lexaria's DehydraTECH-CBD Lowers Blood Glucose Levels in Diabetes Animal Study
April 16, 2024 | InvestorPlace (Ad)
Forget Nvidia, buy this A.I. Stock Now
Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.
May 12, 2023 | marketwatch.com
CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting
May 9, 2023 | benzinga.com
Lexaria Bioscience shares are trading lower after the company priced a 2.1 million unit offering at $0.95 per unit.
May 9, 2023 | msn.com
Lexaria Bioscience prices $2.0M stock offering
May 8, 2023 | benzinga.com
Lexaria's Human Clinical Nicotine Study Completes Dosing as Planned
April 26, 2023 | finance.yahoo.com
LEXX: DehydraTECH CBD May Offer New Mechanism of Action
March 4, 2023 | finanznachrichten.de
Lexaria Bioscience Corp.: Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels
February 22, 2023 | nasdaq.com
Lexaria Bioscience Corp. Common Stock (LEXX)
September 26, 2022 | finance.yahoo.com
Lexaria Bioscience Corp. (LEXX)
August 31, 2022 | finance.yahoo.com
Lexaria Receives New Patent in Mexico
August 12, 2022 | marketwatch.com
NetworkNewsAudio - Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments
August 12, 2022 | marketwatch.com
CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Positive FDA Feedback Concerning Opening IND Program
August 11, 2022 | apnews.com
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
August 11, 2022 | finance.yahoo.com
Lexaria Discusses Valuation Metrics for Biotech Industry
August 10, 2022 | finance.yahoo.com
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension
July 27, 2022 | msn.com
Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
June 21, 2022 | finance.yahoo.com
Lexaria Signs Manufacturing and License Agreements with BevNology
June 21, 2022 | seekingalpha.com
Lexaria stock soars 19% on 2 manufacturing/license agreements with BevNology
June 3, 2022 | seekingalpha.com
Lexaria inks licensing deal for drug delivery tech with Premier Wellness for Japanese market
See More Headlines
Receive LXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CNSX
Sector
Consumer Defensive
Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
CNSX:LXX
CUSIP
N/A
CIK
N/A
Web
www.lexariaenergy.com
Phone
250-765-6424
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Christopher A. Bunka (Age 57)
    Chairman & CEO
  • Mr. John M. Docherty (Age 50)
    Pres & Director
  • Mr. Allan Spissinger (Age 50)
    CFO, Corp. Sec. & Treasurer
  • Mr. Alex Blanchard
    Mang. Corp. Communications & Investor Relations
  • Dr. Edward Ergenzinger
    Chief Legal Officer & Sr. VP of Innovation

Key Competitors

View All Competitors

LXX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), CRISPR Therapeutics (CRSP), KushCo (KSHB), Brigham Minerals (MNRL), Vapor Group (VPOR) and Arbor Realty Trust (ABR).

How do I buy shares of Lexaria Bioscience?

Shares of LXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:LXX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Investment of the Decade…
Porter & Company
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
You won't believe what Citigroup just did to it's depositors
American Alternative
The #1 Crypto for 2024
InvestorPlace
The Greatest Bull Market in Crypto History…
Weiss Ratings
The “Perfect Storm” for Gold
Gold Safe Exchange